NO20071030L - Immunogene komplekser, metoder for fremstilling derav og bruk av samme i farmasoytiske sammensetninger. - Google Patents

Immunogene komplekser, metoder for fremstilling derav og bruk av samme i farmasoytiske sammensetninger.

Info

Publication number
NO20071030L
NO20071030L NO20071030A NO20071030A NO20071030L NO 20071030 L NO20071030 L NO 20071030L NO 20071030 A NO20071030 A NO 20071030A NO 20071030 A NO20071030 A NO 20071030A NO 20071030 L NO20071030 L NO 20071030L
Authority
NO
Norway
Prior art keywords
preparation
methods
same
pharmaceutical compositions
complexes
Prior art date
Application number
NO20071030A
Other languages
English (en)
Inventor
Christine Libon
Thien Nguyen
Original Assignee
Pf Medicament
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pf Medicament filed Critical Pf Medicament
Publication of NO20071030L publication Critical patent/NO20071030L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/385—Haptens or antigens, bound to carriers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/60—Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
    • A61K2039/6031—Proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/18011—Paramyxoviridae
    • C12N2760/18511—Pneumovirus, e.g. human respiratory syncytial virus
    • C12N2760/18522—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Animal Behavior & Ethology (AREA)
  • Molecular Biology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Virology (AREA)
  • Genetics & Genomics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Analytical Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Oppfinnelsen angår en fremgangsmåte for å forbedre immunogenisiten til et immunogen, antigen eller hapten, ved hjelp av binding til et lite støtte peptid. Mer spesifikt, angår oppfinnelsen en fremgangsmåte for fremstilling av et immunogent kompleks, så vel som kompleksene son kan bli oppnådd ved en slik fremgangsmåte, og anvendelsen av nevnte komplekser som et legemiddel for å øke immunogenisiten til et immunogen. Oppfinnelsen omfatter, for eksempel, et støtte peptid som er bundet til et peptid fra G proteinet av respiratorisk syncytialt virus (RSV) og anvendelsen derav som en vaksine for behandlingen av respiratoriske infeksjoner forbundet med RSV.
NO20071030A 2004-07-23 2007-02-23 Immunogene komplekser, metoder for fremstilling derav og bruk av samme i farmasoytiske sammensetninger. NO20071030L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0408175A FR2873378A1 (fr) 2004-07-23 2004-07-23 Complexes immunogenes, leur procede de preparation et leur utilisation dans des compositions pharmaceutiques
PCT/FR2005/001913 WO2006018527A1 (fr) 2004-07-23 2005-07-25 Complexes immunogenes, leur procede de preparation et leur utilisation dans des compositions pharmaceutiques

Publications (1)

Publication Number Publication Date
NO20071030L true NO20071030L (no) 2007-04-23

Family

ID=34947471

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20071030A NO20071030L (no) 2004-07-23 2007-02-23 Immunogene komplekser, metoder for fremstilling derav og bruk av samme i farmasoytiske sammensetninger.

Country Status (14)

Country Link
US (1) US20080300382A1 (no)
EP (1) EP1776379A1 (no)
JP (1) JP2008512986A (no)
KR (1) KR20070058457A (no)
CN (1) CN1989150A (no)
AU (1) AU2005273779A1 (no)
BR (1) BRPI0513741A (no)
CA (1) CA2574340A1 (no)
FR (1) FR2873378A1 (no)
IL (1) IL180900A0 (no)
MX (1) MX2007000887A (no)
NO (1) NO20071030L (no)
RU (1) RU2007106900A (no)
WO (1) WO2006018527A1 (no)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8563002B2 (en) 2007-12-24 2013-10-22 Glaxosmithkline Biologicals, S.A. Recombinant RSV antigens
KR20110045008A (ko) * 2008-07-18 2011-05-03 아이디 바이오메디컬 코포레이션 오브 퀘벡 키메라 호흡기 세포융합 바이러스 폴리펩티드 항원
PL2445526T3 (pl) 2009-06-24 2017-08-31 Glaxosmithkline Biologicals S.A. Rekombinowane antygeny rsv
SG176807A1 (en) 2009-06-24 2012-01-30 Id Biomedical Corp Quebec Vaccine
EP4183412B1 (en) 2009-07-15 2024-08-14 GlaxoSmithKline Biologicals SA Rsv f protein compositions and methods for making same
CN102695523A (zh) 2009-09-10 2012-09-26 诺华有限公司 针对呼吸道疾病的组合疫苗
RS56748B1 (sr) 2011-05-13 2018-03-30 Glaxosmithkline Biologicals Sa Pre-fuzioni rsv f antigeni
US20220065857A1 (en) * 2018-12-12 2022-03-03 The Johns Hopkins University Hiv serosignatures for cross-sectional incidence estimation

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2726471B1 (fr) * 1994-11-07 1997-01-31 Pf Medicament Procede pour ameliorer l'immunogenicite d'un compose immunogene ou d'un haptene et application a la preparation de vaccins
FR2798292A1 (fr) * 1999-09-09 2001-03-16 Pf Medicament Utilisation d'ammoniums quaternaires aliphatiques pour induire une reponse mixte th1/th2
FR2827606A1 (fr) * 2001-07-20 2003-01-24 Pf Medicament Nouveaux derives d'anatoxines diphteriques et leur utilisation comme porteur

Also Published As

Publication number Publication date
KR20070058457A (ko) 2007-06-08
JP2008512986A (ja) 2008-05-01
AU2005273779A1 (en) 2006-02-23
CN1989150A (zh) 2007-06-27
EP1776379A1 (fr) 2007-04-25
WO2006018527A1 (fr) 2006-02-23
CA2574340A1 (fr) 2006-02-23
IL180900A0 (en) 2007-07-04
BRPI0513741A (pt) 2008-05-13
US20080300382A1 (en) 2008-12-04
MX2007000887A (es) 2007-03-12
RU2007106900A (ru) 2008-09-10
FR2873378A1 (fr) 2006-01-27

Similar Documents

Publication Publication Date Title
NO20071609L (no) Immunogen sammensetning for anvendelse ved vaksinering mot stafylokokker
WO2004092360A3 (en) The severe acute respiratory syndrome coronavirus
EP2601969A3 (en) Norovirus vaccine formulations
WO2008079372A3 (en) Novel immunogenic compositions for the prevention and treatment of meningococcal disease
WO2006034292A3 (en) Antibodies against and methods for producing vaccines for respiratory syncytial virus
EP2341063A3 (en) Novel immunogenic compositions for the prevention and treatment of meningococcal disease
WO2008064299A3 (en) Methods of reducing porcine circovirus-associated disease outbreaks
MXPA05011110A (es) Composiciones inmunogenicas novedosas para la prevencion y tratamiento de un padecimiento originado por meningococos.
NO20015073D0 (no) Vaksiner
NO20050008L (no) Neisserial vaksinesammensetninger omfattende en kombinasjon av antigener
WO2009009759A3 (en) Yersinia pestis antigens, vaccine compositions, and related methods
NO20090178L (no) Vaksiner for malaria
BRPI1007721B1 (pt) composição de vacina para uso na indução de uma resposta imunológica contra um rotavírus em um indivíduo, cepa de rotavírus isolado de cdc-9 e cepa de rotavírus isolado de cdc-66
RU2016110576A (ru) Бактериальная вакцина и способы ее получения
ES2701084T3 (es) Compuestos inmunogénicos que comprenden péptido gp41 de VIH acoplado a proteína portadora CRM197
JP2011504535A5 (no)
BR112013001168A2 (pt) "toxóide, composição farmacêutica, método de produzir uma antitoxina, antitoxina, e, métodos de tratar um indivíduo intoxicado de vacinação contra a intoxicação por uma toxina e de tratar um mamífero intoxicado."
JP2009501901A5 (no)
WO2003090687A8 (en) Using heat shock proteins to increase immune response
WO2009074861A3 (en) Improved vaccine
JP2009514840A5 (no)
DE60336588D1 (de) Verbesserte anthraximpfstoffe und abgabeverfahren
BRPI0513741A (pt) processo de melhoria da imunogeneicidade de um imunogene, antìgeno ou hapteno, complexo imunogênico, ácido nucleico e utilização de um complexo imunogênico
WO2006027300A3 (en) Carrier conjugates of gnrh-peptides
WO2023235660A3 (en) Flavivirus immunogens and vaccine compositions and methods of using the same

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application